MedTrace Logo

The Copper T380A IUD vs. Oral Levonorgestrel for Emergency Contraception

NCT00966771 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 548

Last updated 2017-02-06

No results posted yet for this study

Summary

The purpose of this study is to see if women presenting for emergency contraception (EC) and choose the copper intrauterine device (IUD) will have fewer unplanned pregnancies in the next year compared to women who choose oral levonorgestrel for EC. The study will also compare use of an effective method of contraception in the year after they received EC.

Conditions

  • Pregnancy

Interventions

DRUG

Copper T380 IUD

copper T 380 IUD

DRUG

Oral levonorgestrel

1.5 mg

Sponsors & Collaborators

Principal Investigators

  • David Turok, MD · University of Utah

Eligibility

Min Age
18 Years
Max Age
30 Years
Sex
FEMALE
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2009-10-31
Primary Completion
2011-08-31
Completion
2011-08-31

Countries

  • United States

Study Locations

More Related Trials

Entities

Companies

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT00966771 on ClinicalTrials.gov